This new patent covers receptor-targeted formulations for the treatment of cardiac hypertrophy, TRPV1-receptor-associated hearing loss and urinary cystitis.
Read Press ReleaseNovel NRCT-101SR shown in previous human studies to be effective and well-tolerated with no side effects
Read Press Release● Faro Health Inc. strengthens its management team, appointing Kimberly C. Pospahala as Vice President of Commercial to accelerate go-to-market efforts to digitally transform clinical protocol design ● Scott Chetham, Ph.D., Co-Founder & CEO of Faro Health, Inc., will present at the SCOPE Conference on Feb. 9, 2022
Read Press ReleaseGb Sciences' collaboration with MSU has received media coverage across the country, starting with an interview from WLNS-TV in Lansing, Michigan, and interviews with Gb Sciences in the magazines 'Cannabis Business Times' and 'Hemp Grower'
Read Press Release